Your browser doesn't support javascript.
loading
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.
Cohen, Mikael; Maillart, Elisabeth; Tourbah, Ayman; De Sèze, Jérôme; Vukusic, Sandra; Brassat, David; Anne, Olivier; Wiertlewski, Sandrine; Camu, William; Courtois, Sylvie; Ruet, Aurélie; Debouverie, Marc; Le Page, Emmanuelle; Casez, Olivier; Heinzlef, Olivier; Stankoff, Bruno; Bourre, Bertrand; Castelnovo, Giovanni; Rico, Audrey; Berger, Eric; Camdessanche, Jean-Philippe; Defer, Gilles; Clavelou, Pierre; Al Khedr, Abdullatif; Zephir, Hélène; Fromont, Agnès; Papeix, Caroline; Brochet, Bruno; Pelletier, Jean; Lebrun, Christine.
Afiliação
  • Cohen M; Department of Neurology, University Hospital of Nice, Nice, France.
  • Maillart E; Department of Neurology, Salpêtrière Hospital, Paris, France.
  • Tourbah A; Department of Neurology, University Hospital of Reims, Reims, France.
  • De Sèze J; Department of Neurology, University Hospital of Strasbourg, Strasbourg, France.
  • Vukusic S; Department of Neurology, University Hospital of Lyon, Lyon, France.
  • Brassat D; Department of Neurology, University Hospital of Toulouse, Toulouse, France.
  • Anne O; Department of Neurology, University Hospital of La Rochelle, La Rochelle, France.
  • Wiertlewski S; Department of Neurology, University Hospital of Nantes, Nantes, France.
  • Camu W; Department of Neurology, University Hospital of Montpellier, Montpellier, France.
  • Courtois S; Department of Neurology, University Hospital of Mulhouse, Mulhouse, France.
  • Ruet A; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France.
  • Debouverie M; Department of Neurology, University Hospital of Nancy, Nancy, France.
  • Le Page E; Department of Neurology, University Hospital of Rennes, Rennes, France.
  • Casez O; Department of Neurology, University Hospital of Grenoble, Grenoble, France.
  • Heinzlef O; Department of Neurology, University Hospital of Poissy, Poissy, France.
  • Stankoff B; Department of Neurology, Tenon Hospital, Paris, France.
  • Bourre B; Department of Neurology, University Hospital of Rouen, Rouen, France.
  • Castelnovo G; Department of Neurology, University Hospital of Nimes, Nimes, France.
  • Rico A; Department of Neurology, University Hospital of Marseille, Marseille, France.
  • Berger E; Department of Neurology, University Hospital of Besançon, Besançon, France.
  • Camdessanche JP; Department of Neurology, University Hospital of Saint Etienne, Saint Etienne, France.
  • Defer G; Department of Neurology, University Hospital of Caen, Caen, France.
  • Clavelou P; Department of Neurology, University Hospital of Clermont Ferrand, Clermont Ferrand, France.
  • Al Khedr A; Department of Neurology, University Hospital of Amiens, Amiens, France.
  • Zephir H; Department of Neurology, University Hospital of Lille, Lille, France.
  • Fromont A; Department of Neurology, University Hospital of Dijon, Dijon, France.
  • Papeix C; Department of Neurology, Salpêtrière Hospital, Paris, France.
  • Brochet B; Department of Neurology, University Hospital of Mulhouse, Mulhouse, France.
  • Pelletier J; Department of Neurology, University Hospital of Nimes, Nimes, France.
  • Lebrun C; Department of Neurology, University Hospital of Nice, Nice, France.
JAMA Neurol ; 71(4): 436-41, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24566807
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propilenoglicóis / Esfingosina / Substituição de Medicamentos / Anticorpos Monoclonais Humanizados / Imunossupressores / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propilenoglicóis / Esfingosina / Substituição de Medicamentos / Anticorpos Monoclonais Humanizados / Imunossupressores / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article